← Back to Clinical Trials
Recruiting NCT07008781

NCT07008781 A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07008781
Status Recruiting
Phase
Sponsor Rutgers, The State University of New Jersey
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2025-05-30
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Youth-led cancer screening intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2025-05-30 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.

Eligibility Criteria

Inclusion Criteria: * Student at New Brunswick Health Sciences Technology High School (15-18 years) and their adult family members (18+ years old) who are NJ residents. * Adults must be eligible for at least one cancer screening other than skin (see below). * Participants must be fluent in either English or Spanish and the youth must speak the same language as the adult. Breast: 40-74 year old women Cervical: 21-65 year old women with a cervix (have not had a hysterectomy) Colorectal: 45-75 year olds Prostate: 50 to 69 year old men (start at 45 for black males) Lung: 50 to 80 year olds who currently smoke or quit within the past 15 years Overall: 21-75 year old women 45-75 year old men 76-80 year olds who currently smoke or quit within the past 15 years Exclusion Criteria: * Students less than 15 years old. * Adults not eligible for a cancer screening of interest. * Unable to speak fluent English or Spanish.

Contact & Investigator

Central Contact

Sara Heinert, PhD, MPH

✉ sara.heinert@rutgers.edu

📞 732-235-7872

Frequently Asked Questions

Who can join the NCT07008781 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 80 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07008781 currently recruiting?

Yes, NCT07008781 is actively recruiting participants. Contact the research team at sara.heinert@rutgers.edu for enrollment information.

Where is the NCT07008781 trial being conducted?

This trial is being conducted at New Brunswick, United States.

Who is sponsoring the NCT07008781 clinical trial?

NCT07008781 is sponsored by Rutgers, The State University of New Jersey. The trial plans to enroll 84 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology